However, when the same panel of markers, excluding CRP, was tested in a prospective multicenter trial of more than 1,100 patients who presented with symptoms suggestive of stroke, a 86% sensitivity and 37% specificity were achieved for distinguishing stroke from mimics in the first 24 h after symptom onset (59). The gene discussed is CRP; the disease is Stroke.